HyperMabs is a biopharmaceutical company that designs and develops
innovative monoclonal antibody-based therapeutics for life threatening
diseases including COVID-19. We believe in connecting rigorous science with
our innate sense of urgency to rapidly generate breakthrough therapies for
patients in need of a better quality of life. Our highly qualified team of drug
developers and company builders has a track record of advancing complex
biologics from discovery through clinical trials.
Company Details
- Employees
- 19
- Address
- 750 Boulevard Saint-Laurent, Montreal,quebec H2y 2z4,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.hypermabs.com
- Keywords
- Laval.
- HQ
- Montreal, Quebec
Hypermabs Inc. Questions
Hypermabs Inc.'s website is http://www.hypermabs.com
Hypermabs Inc.'s LinkedIn profile is https://ca.linkedin.com/company/hypermabs
Hypermabs Inc. has
19 employees.
View email and phone details for 19
employees at Hypermabs Inc..
Hypermabs Inc.'s industry is
Biotechnology Research
Hypermabs Inc.'s top competitors are
Forbius,
Ixm Labs,
Cellcarta,
35pharma,
Paraza Pharma Inc.,
Congruence Therapeutics,
Pharmascience,
Grace Therapeutics, Inc.,
Repare Therapeutics,
Altasciences.
Hypermabs Inc.'s categories are Biotechnology Research
